48 biomarkers
| Chapter | Eye_Biomarker | Systematic_Disease | Category |
|---|---|---|---|
| Chapter XIII | affecting the cornea | rheumatic diseases (RA) | Disease |
| Chapter XIII | affecting the cornea | sjögren's syndrome | Disease |
| Chapter XIII | anti-fumarase antibody | autoimmune diseases | Protein |
| Chapter XIII | anti-tubulin-α-1c antibody | Behçet's disease (BD) | Protein |
| Chapter XIII | cataract | Behçet's disease (BD) | Disease |
| Chapter XIII | CD30 cells are increased in lacrimal glands and conjunctiva | sjögren's syndrome | Other |
| Chapter XIII | choroidal vascularity index | systemic lupus erythematosus (SLE) | Bio-imaging |
| Chapter XIII | decrease in retinal vessel density | systemic lupus erythematosus (SLE) | Bio-imaging |
| Chapter XIII | diplopia and ptosis | myositis with anti-mitochondrial antibody type 2 | Symptom |
| Chapter XIII | dry eye disease (DED) | rheumatic diseases (RA) | Disease |
| Chapter XIII | endothelial progenitor cells | Behçet's disease (BD) | Other |
| Chapter XIII | ERAP1 | Behçet's disease (BD) | Nucleic Acids-Based Biomarker |
| Chapter XIII | HLA-B | Behçet's disease (BD) | Protein |
| Chapter XIII | ICAM-1 | Sicca syndrome [Sjögren] | Protein |
| Chapter XIII | ICG-A | systemic lupus erythematosus (SLE) | Bio-imaging |
| Chapter XIII | IL-18 | Behçet's disease (BD) | Cytokine |
| Chapter XIII | IL-33 and its receptor soluble ST2 (sST2) | Behçet's disease (BD) | Cytokine |
| Chapter XIII | IL-6 | Behçet's disease (BD) | Cytokine |
| Chapter XIII | IL-8 | Behçet's disease (BD) | Cytokine |
| Chapter XIII | interleukin-2 (IL-2) and soluble interleukin-2 receptor (sIL-2R) | Behçet's disease (BD) | Cytokine |
| Chapter XIII | LC-MS of tears | primary Sjögren's syndrome (pSS) | Protein |
| Chapter XIII | matrix metalloproteinases (MMPs) | takayasu's arteritis | Protein |
| Chapter XIII | neutrophil to lymphocyte ratio (NLR) | Behçet's disease (BD) | Other |
| Chapter XIII | ocular pulse amplitude | giant cell arteritis | Eye measures |
| Chapter XIII | ophthalmic disorders | rheumatic diseases (RA) | Other |
| Chapter XIII | overexpression of proteins STOM, ANXA4 and ANXA1 in tear fluid | primary Sjögren's syndrome (pSS) | Protein |
| Chapter XIII | plasma-soluble urokinase plasminogen activator receptor (suPAR) | Behçet's disease (BD) | Protein |
| Chapter XIII | prefoldin 5 and anti-prefoldin 5 antibodies | ankylosing Spondylitis | Protein |
| Chapter XIII | retinal nerve fiber layer and macular thinning | systemic lupus erythematosus (SLE) | Bio-imaging |
| Chapter XIII | retinal nerve fibre layer thickness, multifocal electroretinography | chloroquine toxicity in Rheumatoid Arthritis(RA) | Bio-imaging |
| Chapter XIII | retinal vessel morphology | rheumatic diseases (RA) | Bio-imaging |
| Chapter XIII | retinopathy | SLE-Systemic Lupus Erythematosus | Bio-imaging |
| Chapter XIII | serum amyloid-A | Behçet's disease (BD) | Protein |
| Chapter XIII | SPRR1B | Sicca syndrome [Sjögren] | Protein |
| Chapter XIII | sTNFR-75 | Behçet's disease (BD) | Protein |
| Chapter XIII | tear fluid protein changes | rheumatic diseases (RA) | Protein |
| Chapter XIII | the increase in Choroidal thickness | rheumatic diseases (RA) | Bio-imaging |
| Chapter XIII | the scores of eye's sign in bulbar conjunctival microvascular changes | systemic lupus erythematosus (SLE) | Eye measures |
| Chapter XIII | TSPO-NOX1 axis | autoimmune diseases | Protein |
| Chapter XIII | tuberculosis exposure | Behçet's disease (BD) | Other |
| Chapter XIII | urinary neopterin | Sicca syndrome [Sjögren] | Metabolite |
| Chapter XIII | uveitis | autoimmune diseases | Other |
| Chapter XIII | uveitis | Behçet's disease (BD) | Disease |
| Chapter XIII | uveitis | Behçet's disease (BD) | Disease |
| Chapter XIII | uveitis | Behçet's disease (BD) | Disease |
| Chapter XIII | uveitis | arthritis | Other |
| Chapter XIII | vasculitic central retinal vein occlusion | rheumatic diseases (RA) | Disease |
| Chapter XIII | visual field test | chloroquine toxicity in Rheumatoid Arthritis(RA) | Eye measures |